SCHEMBL30036639

SCHEMBL30036639

CN(C(=O)c1cccc(CC=O)c1)c1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.55
HTT P42858 2/20 0.55
NPC1 O15118 2/20 0.55
RAB9A P51151 2/20 0.55
ALDH1A1 P00352 1/20 0.55
MAPT P10636 1/20 0.55
HPGD P15428 1/20 0.55
MDM2 Q00987 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
GPR55 Q9Y2T6 1/20 0.55
KMT2A Q03164 4/20 0.52
MEN1 O00255 1/20 0.51
KDM1A O60341 2/20 0.51
MAOA P21397 2/20 0.51
PLAU P00749 1/20 0.51
MAOB P27338 1/20 0.51
KDM4E B2RXH2 1/20 0.49
TSHR P16473 1/20 0.47
ATM Q13315 1/20 0.47
EGFR P00533 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18780834 0.85 L3MBTL1 (0.57) L3MBTL1HTTNPC1RAB9AALDH1A1
SCHEMBL13525179 0.85 L3MBTL1 (0.57) L3MBTL1HTTNPC1RAB9AALDH1A1
SCHEMBL18201849 0.83 KMT2A (0.50) L3MBTL1NPC1RAB9AHPGDSMN1; SMN2
SCHEMBL30036881 0.82 L3MBTL1 (0.55) L3MBTL1HTTNPC1RAB9AALDH1A1
SCHEMBL1696343 0.82 L3MBTL1 (0.55) L3MBTL1HTTNPC1RAB9AALDH1A1
SCHEMBL9001650 0.82 MAOA (0.63) L3MBTL1HTTNPC1RAB9AALDH1A1
SCHEMBL13524672 0.81 L3MBTL1 (0.54) L3MBTL1HTTNPC1RAB9AALDH1A1
SCHEMBL1690490 0.81 L3MBTL1 (0.54) L3MBTL1HTTNPC1RAB9AALDH1A1
SCHEMBL14039447 0.78 KMT2A (0.51) L3MBTL1HTTNPC1RAB9AALDH1A1
SCHEMBL32688152 0.78 KDM1A (0.58) L3MBTL1HTTNPC1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4096661-A1 COMPOUNDS AND COMPOSITIONS FOR USE IN TREATING SKIN DISORDERS Kamari Pharma Ltd. (IL) 2022-12-07 EP disclosed